Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 292.00 | N/A |
| PEG Ratio (TTM) | -61.32 | N/A |
| P/S Ratio (TTM) | 3.09 | N/A |
| P/B Ratio (TTM) | 1.00 | N/A |
| P/FCF Ratio (TTM) | 21.48 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.30 | N/A |
| Price to 5YR AVG FCF Ratio | 25.14 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.04% | N/A |
| ROE (TTM) | 0.44% | N/A |
| Net Profit Margin (TTM) | 1.05% | N/A |
| ROIC 5YR AVG | 8.43% | N/A |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 132.34% | 33.05% | 32.68% |
| Revenue | 35.78% | 8.41% | 9.74% |
| Net Income | 117.85% | 23.31% | 32.49% |
| Cash Flow | 28.88% | 13.11% | 68.26% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.33 | N/A |
| Quick Ratio (TTM) | 0.33 | N/A |
| D/E Ratio (TTM) | 0.56 | N/A |
| Interest Coverage (TTM) | 0.82 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 5.25 | N/A |
| Shares Outstanding Growth 5YR AVG | 8.00% | N/A |